Stallion India Fluorochemicals Reports Q1FY27 Monitoring Agency Report
Stallion India Fluorochemicals Limited's Monitoring Agency Report for Q1FY27 shows ₹192.91 crore utilized from its ₹363.93 crore Rights Issue as of June 30, 2026. Unutilized proceeds amount to ₹171.02 crore. No deviations from the Offer Document's objectives were noted. Land acquisition and manufacturing facility construction are progressing.
This is a routine regulatory filing providing an update on fund utilization. It does not contain any new business developments, financial results, or strategic changes that would significantly impact the company's stock or operations.
The report is a routine monitoring agency update on the utilization of rights issue proceeds. It confirms no deviations from the planned use of funds, which is a neutral outcome. There are no significant positive or negative developments reported.
Stallion India Fluorochemicals Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by Infomerics Valuation and Rating Limited, details the utilization of proceeds from the company's Rights Issue.
The Rights Issue, which opened on February 20, 2026, and closed on February 27, 2026, raised approximately ₹363.93 crore through the issuance of 3,67,60,483 equity shares at ₹99 per share.
As of June 30, 2026, a total of ₹192.91 crore has been utilized from the issue proceeds. This includes ₹75.08 crore utilized in Q4FY26 and ₹117.83 crore in Q1FY27. The unutilized amount stands at ₹171.02 crore, which is available for use in subsequent quarters.
The report confirms that there have been no deviations from the objects outlined in the Offer Document. The cost structure for the rights issue remains unchanged at ₹363.93 crore across all heads, including acquisition of land, construction of manufacturing facility, issue-related expenses, and general corporate purposes.
Progress in the object(s) shows that the acquisition of land is underway, with ₹4.23 crore utilized as of June 30, 2026. For the construction of the manufacturing facility, ₹113.61 crore has been utilized as of the same date. Issue-related expenses have been fully utilized, and ₹7.83 crore has been allocated for general corporate purposes, with no utilization reported yet for this category.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.